Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 4,800.00
+100.00 (2.13%)
At close: Mar 27, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 33.69 billion as of March 27, 2026. Its market cap has increased by 6.79% in one year.
Market Cap
33.69B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,800.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 33.69B, a decrease of -59.32%. That is a compound annual growth rate of -21.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 33.69B | 0.42% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eagle Veterinary Technology Co.,Ltd | 49.94B |
| GeneBioTech Co. ,Ltd | 44.52B |
| Korean Drug | 43.54B |
| HLscience | 38.15B |
| Seoul Pharma | 32.47B |
| Daesung Microbiological Labs. | 32.03B |
| ChoA Pharmaceutical Co., LTD. | 28.01B |
| Pharmsville | 26.82B |